The road ahead: potential challenges facing CRISPR/Cas patents

Since Anton van Leeuwenhoek first discovered bacteria, these tiny single-cell organisms have been pivotal to major scientific advances. In fact, some of the biggest advances in medicine can be attributed to these unicellular microorganisms.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York

The road ahead: potential challenges facing CRISPR/Cas patents

Editor's picks

Editor's picks

More features